Literature DB >> 18299298

Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?

Charles A Herzog1, Jeremy W Strief, Allan J Collins, David T Gilbertson.   

Abstract

INTRODUCTION: The risk of death after coronary revascularization is markedly higher for dialysis patients than for the general population and the cause is inadequately explained. We analyzed cause-specific mortality of dialysis patients after coronary revascularization.
METHODS: This was a retrospective analysis of dialysis patients hospitalized for first surgical coronary revascularization after renal replacement therapy initiation from 1 January 1999 to 31 December 2002. Patients were identified from the US Renal Data System database (n = 1,516,251) by the International Classification of Diseases, Ninth Edition, Clinical Modification code for coronary artery bypass (CAB) surgery (36.1x). Endpoints were deaths due to all causes, all cardiac causes, cardiac arrest or arrhythmia, myocardial infarction, infection and other causes. Cause-specific mortality information was obtained from Centers for Medicare & Medicaid Services End-Stage Renal Disease Death Notification form (CMS 2746-U3).
RESULTS: For CAB patients (n = 5830), the all-cause mortality rate was 290 per 1000 patient-years and the rate for arrhythmically mediated deaths was 76 per 1000 patient-years. The largest cause of attributable mortality is cardiac arrest or arrhythmia, accounting for approximately one-fourth of all-cause mortality.
CONCLUSIONS: The risk of arrhythmically mediated death may contribute to poor long-term outcomes after coronary revascularization in dialysis patients. A treatment strategy employing coronary revascularization and other interventions to reduce the sudden cardiac death risk might improve long-term survival.

Entities:  

Mesh:

Year:  2008        PMID: 18299298      PMCID: PMC2727291          DOI: 10.1093/ndt/gfn038

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  22 in total

1.  Sudden cardiac death in the United States, 1989 to 1998.

Authors:  Z J Zheng; J B Croft; W H Giles; G A Mensah
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

2.  Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Authors:  P B Mark; N Johnston; B A Groenning; J E Foster; K G Blyth; T N Martin; T Steedman; H J Dargie; A G Jardine
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

3.  Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction.

Authors:  G D Veenhuyzen; S N Singh; D McAreavey; B J Shelton; D V Exner
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

4.  ICD implantation with and without combined myocardial revascularisation--incidence of ICD therapy and late survival.

Authors:  C Brockes; M Rahn-Schönbeck; F Duru; R Candinas; B Seifert; M Turina
Journal:  Thorac Cardiovasc Surg       Date:  2002-12       Impact factor: 1.827

5.  Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.

Authors:  James R Cook; Carlos Rizo-Patron; Anne B Curtis; Anne M Gillis; J Thomas Bigger; Steven P Kutalek; James Coromilas; Bradley I Hofer; Judy Powell; Alfred P Hallstrom
Journal:  Am Heart J       Date:  2002-05       Impact factor: 4.749

6.  Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.

Authors:  Michael V Rocco; Guofen Yan; Jennifer Gassman; Julia Breyer Lewis; Daniel Ornt; Barbara Weiss; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-01       Impact factor: 8.860

7.  Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin?

Authors:  K Amann; M Buzello; A Simonaviciene; G Miltenberger-Miltenyi; A Koch; A Nabokov; M L Gross; B Gless; G Mall; E Ritz
Journal:  Nephrol Dial Transplant       Date:  2000-07       Impact factor: 5.992

8.  Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial.

Authors:  T Bruce Ferguson; Eric D Peterson; Laura P Coombs; Mary C Eiken; Meghan L Carey; Frederick L Grover; Elizabeth R DeLong
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

9.  Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy.

Authors:  Timo H Mäkikallio; Petra Barthel; Raphael Schneider; Axel Bauer; Jari M Tapanainen; Mikko P Tulppo; Juha S Perkiömäki; Georg Schmidt; Heikki V Huikuri
Journal:  Am J Cardiol       Date:  2005-12-22       Impact factor: 2.778

10.  Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes.

Authors:  Charles A Herzog; Jennie Z Ma; Allan J Collins
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more
  23 in total

Review 1.  Sudden cardiac death in end stage renal disease: unlocking the mystery.

Authors:  D Zachariah; P R Kalra; Paul R Roberts
Journal:  J Nephrol       Date:  2014-11-13       Impact factor: 3.902

Review 2.  Sudden cardiac death in chronic kidney disease: epidemiology and prevention.

Authors:  M Khaled Shamseddin; Patrick S Parfrey
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

Review 3.  The potential of electrocardiography for cardiac risk prediction in chronic and end-stage kidney disease.

Authors:  Sofia Skampardoni; Dimitrios Poulikakos; Marek Malik; Darren Green; Philip A Kalra
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

4.  Predictors and prognostic implications of major adverse cardiovascular events after renal transplant: 10 years outcomes in 321 patients.

Authors:  Waqas Aftab; Padmini Varadarajan; Shuja Rasool; Ramdas G Pai
Journal:  Int J Angiol       Date:  2014-06

5.  The effect of uraemia on the duration of arrhythmias in the context of cardioprotective ischaemic conditioning strategies.

Authors:  Kieran McCafferty; Conor J Byrne; Julius Kieswich; Martin Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Heart Asia       Date:  2014-05-24

Review 6.  Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.

Authors:  Francesco Summaria; Maria Benedetta Giannico; Giovanni Paolo Talarico; Roberto Patrizi
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-16

7.  Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis.

Authors:  Jonathan W Waks; Larisa G Tereshchenko; Rulan S Parekh
Journal:  J Electrocardiol       Date:  2016-07-28       Impact factor: 1.438

8.  Cause of Death in Patients with Reduced Kidney Function.

Authors:  Stephanie Thompson; Matthew James; Natasha Wiebe; Brenda Hemmelgarn; Braden Manns; Scott Klarenbach; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2015-03-02       Impact factor: 10.121

9.  Electrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients.

Authors:  Silvia Badarau; Dimitrie Siriopol; Daniela Drugus; Raluca Dumea; Simona Hogas; Mihaela Blaj; Luminita Voroneanu; Angelica Gramaticu; Antoniu Petris; Alexandru Burlacu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

10.  Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.

Authors:  Mark R Marshall; Alain C Vandal; Janak R de Zoysa; Ruvin S Gabriel; Imad A Haloob; Christopher J Hood; John H Irvine; Philip J Matheson; David O R McGregor; Kannaiyan S Rabindranath; John B W Schollum; David J Semple; Zhengxiu Xie; Tian Min Ma; Rose Sisk; Joanna L Dunlop
Journal:  J Am Soc Nephrol       Date:  2020-03-18       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.